Fluticasone Propionate
₹100.00
Documentation / approvals : tdp, usdmf, edmf, cep/cos, dmf open part, dmf closed part, jdmf
It is used to treat asthma and allergic rhinitis. It exhibits excellent anti- inflammatory feature.
Application :
- Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the metabolism of carbohydrates and, to a lesser extent, fat and protein.
- It is used to treat asthma, allergic rhinitis, nasal polyps, various skin disorders and Crohn”s disease and ulcerative colitis. It is also used to treat eosinophilic.
- Nasal spray preparation of fluticasone propionate is used in the prophylaxis and treatment of allergic rhinitis.
- Fluticasone propionate is a highly selective agonist at the glucocorticoid receptor.
- It has been shown to have a wide range of inhibitory effects on multiple cell types and mediators involved in inflammation.
Features:
- Effective
- Affordable
- Safe to use
Chemical Details:
- Formula: C25H31F3O5S
- Mol. mass: 500.57 g/mol
Product Type API
Description
Dose | ANY |
Product Type | API |
Packaging Type | EXPOERT WORTHY |
Usage | Commercial |
Packaging Size | EXPOERT WORTHY |
Our Export Location as a Fluticasone Propionate Manufacturer, Supplier, Exporter, Stockist from India.
Afghanistan
Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Austrian Empire Azerbaijan Baden Bahamas Bahrain Bangladesh Barbados Bavaria Belarus Belgium Belize Benin (Dahomey) Bolivia Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mecklenburg-Schwerin Mecklenburg-Strelitz Mexico Micronesia Moldova Monaco Mongolia Montenegro |
Bosnia and Herzegovina
Botswana Brazil Brunei Brunswick and Lüneburg Bulgaria Burkina Faso Burma Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Central American Federation Chad Chile China Colombia Comoros Congo Free State Costa Rica Morocco Mozambique Namibia Nassau Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria North German Confederation North German Union North Macedonia Norway Oldenburg Oman Orange Free State Pakistan Palau Panama Papal States |
Cote d’Ivoire Croatia Cuba Cyprus Czechia Czechoslovakia Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Duchy of Parma East Germany Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Federal Government of Germany Fiji Papua New Guinea Paraguay Peru Philippines Piedmont-Sardinia Poland Portugal Qatar Republic of Genoa* Republic of Korea (South Korea) Republic of the Congo Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia |
Schaumburg-Lippe* Finland France Gabon Gambia Georgia Germany Ghana Grand Duchy of Tuscany Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Hanover Hanseatic Republics Hawaii Hesse Holy See Honduras Hungary Iceland Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syria Tajikistan Tanzania Texas Thailand |
India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kingdom of Serbia/Yugoslavia Kiribati Korea Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Lew Chew (Loochoo) Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Two Sicilies* Uganda Ukraine Union of Soviet Socialist Republics* United Arab Emirates United Kingdom Uruguay Uzbekistan Vanuatu Venezuela Vietnam Württemberg* Yemen Zambia Zimbabwe |
Reviews
There are no reviews yet.